Results 11 to 20 of about 19,193 (244)

Transjugular Intrahepatic Portosystemic Shunt [PDF]

open access: yesClinical privilege white paper, 2020
The transjugular intrahepatic portosystemic shunt (TIPS) is a percutaneous procedure designed to decompress the portal system in patients with portal hypertension. TIPS is indicated as prophylaxis for recurrent variceal bleeding, refractory active variceal bleeding, and refractory ascites or hepatic hydrothorax.
Jennifer Kissane   +2 more
semanticscholar   +3 more sources

Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices [PDF]

open access: yesKorean Journal of Radiology, 2017
OBJECTIVE: Although a transjugular intrahepatic portosystemic shunt (TIPS) is commonly placed to manage isolated gastric varices, balloon-occluded retrograde transvenous obliteration (BRTO) has also been used. We compare the long-term outcomes from these
Kim, Seung Kwon   +3 more
core   +4 more sources

First Report of Fulminant Budd-Chiari Syndrome Treated by Direct Intrahepatic Portocaval Shunt in Vietnam

open access: yesCase Reports in Gastroenterology, 2021
Budd-Chiari syndrome (BCS) is a rare disorder caused by hepatic venous outflow obstruction that can lead to acute liver failure proposing liver transplantation or transjugular intrahepatic portosystemic shunt.
Thai Van Nguyen   +3 more
doaj   +1 more source

Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy—A Review of the Past Decade’s Literature Focusing on Incidence, Risk Factors, and Prophylaxis

open access: yesJournal of Clinical Medicine, 2023
Transjugular intrahepatic portosystemic shunt (TIPS) is an established treatment for portal hypertension and its’ complications in liver cirrhosis, yet the development of hepatic encephalopathy (HE) remains a significant concern.
Karina Holm Friis   +5 more
semanticscholar   +1 more source

The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions

open access: yesHepatology, 2022
In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt (TIPS) placement improves control of ascites and may reduce mortality.
P. Deltenre   +4 more
semanticscholar   +1 more source

Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model

open access: yesHepatology, 2022
Background and Aims: Implantation of a transjugular intrahepatic portosystemic shunt (TIPS) improves survival in patients with cirrhosis with refractory ascites and portal hypertensive bleeding.
F. Vizzutti   +33 more
semanticscholar   +1 more source

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

open access: yesHepatology, EarlyView., 2022
The river diagram demonstrates that after transjugular intrahepatic portosystemic shunt insertion (TIPS) the majority of patients without ascites and 50% of the patients with ascites detectable at ultrasound, show the best response in the long term follow‐up.
Alexander Queck   +14 more
wiley   +1 more source

Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury

open access: yesThe Turkish Journal of Gastroenterology, 2023
Background: Hepatic encephalopathy, which is a serious complication, and sarcopenia are undesirable consequences in cirrhosis. Transjugular intrahepatic portosystemic shunt increases the risk of hepatic encephalopathy.
Puja Bhatia Kapoor   +7 more
semanticscholar   +1 more source

Transjugular Intrahepatic Portosystemic Shunt [PDF]

open access: yesClinics in Liver Disease, 2014
Transjugular intrahepatic portosystemic shunt (TIPS) is an established procedure for the complications of portal hypertension. The largest body of evidence for its use has been supported for recurrent or refractory variceal bleeding and refractory ascites.
Kavish R, Patidar   +2 more
openaire   +2 more sources

Health disparities in chronic liver disease

open access: yesHepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy